These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays. Rees DG; Hartley MG; Green M; Lukaszewski RA; Griffin KF; Atkins HS; Lyons R; Krieg AM; Titball RW Microb Pathog; 2013 Oct; 63():16-8. PubMed ID: 23707360 [TBL] [Abstract][Full Text] [Related]
25. [Tularemia vaccine strain is a potential vector]. Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276 [TBL] [Abstract][Full Text] [Related]
26. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial. Mulligan MJ; Stapleton JT; Keitel WA; Frey SE; Chen WH; Rouphael N; Edupuganti S; Beck A; Winokur PL; El Sahly HM; Patel SM; Atmar RL; Graham I; Anderson E; El-Kamary SS; Pasetti MF; Sztein MB; Hill H; Goll JB; Vaccine; 2017 Aug; 35(36):4730-4737. PubMed ID: 28750854 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Green M; Choules G; Rogers D; Titball RW Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452 [TBL] [Abstract][Full Text] [Related]
28. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631 [TBL] [Abstract][Full Text] [Related]
29. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge. Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555 [TBL] [Abstract][Full Text] [Related]
30. Vaccines against Francisella tularensis. Wayne Conlan J; Oyston PC Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730 [TBL] [Abstract][Full Text] [Related]
31. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751 [TBL] [Abstract][Full Text] [Related]
32. Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man. Tärnvik A; Eriksson M; Sandström G; Sjöstedt A Immunology; 1992 Jul; 76(3):349-54. PubMed ID: 1526645 [No Abstract] [Full Text] [Related]
36. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Kirimanjeswara GS; Olmos S; Bakshi CS; Metzger DW Immunol Rev; 2008 Oct; 225():244-55. PubMed ID: 18837786 [TBL] [Abstract][Full Text] [Related]
37. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses. Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348 [TBL] [Abstract][Full Text] [Related]